Visiongain publishes Colon Targeting Drug Delivery Market 2020-2030 report

How this report will benefit you How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in thissector. The 232-page Visiongain report provides clear detailed insight into the colon targeting drug delivery market. Discover the key trends and development in the market. ThisVisiongainreport includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today. By ordering...

LONDON, 31/08/2020 (informazione.news - comunicati stampa - editoria e media)

Read on to discover how you can exploit the future business opportunities emerging in this sector.

The 232-page Visiongain report provides clear detailed insight into the colon targeting drug delivery market. Discover the key trends and development in the market.

This Visiongain report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

By ordering and reading our brand-new report today you stay better informed and ready to act.

– Primary Approaches for CDDS

– pH Sensitive Polymer Coated Drug Delivery to the Colon

– Delayed (Time Controlled Release System) Release Drug Delivery to Colon

– Microbially Triggered Drug Delivery to Colon

• Prodrug Approach for Drug Delivery to Colon

• Azo-Polymeric Prodrugs

• Polysaccharide Based Delivery Systems

– Newly Developed Approaches for CDDS categorized into:

– Pressure Controlled Drug-Delivery Systems

– Novel Colon Targeted Delivery System (CODESTM)

– Osmotic Controlled Drug Delivery (ORDS-CT)

– Others

– Natural Polymers

– Pectin

– Guar gum

– Dextran

– Chitosan

– Amylose

– Chondroitin Sulfate

– Inulin

– Cyclodextrin

– Locust bean gum

– Others

– Synthetic Polymers

This report discusses the market trends and developments of each submarket.

• Baxter International Inc.

• 3M Health Care

• Bayer AG

• Boston Scientific Corporation

• F. Hoffmann-La Roche AG

• GlaxoSmithKline PLC

• Johnson and Johnson

• Novartis AG

• Sanofi SA

• Bausch Health

 

3M Health Care

Bausch Health

Baxter International Inc.

Bayer AG

Boston Scientific Corporation

F. Hoffmann-La Roche AG

GlaxoSmithKline PLC

Johnson and Johnson

Novartis AG

Sanofi SA

American Cancer Society

American College of Gastroenterology

Centers for Disease Control and Prevention (CDC)

Institute for Health Metrics and Evaluation

National Center for Biotechnology Information (NCBI)

Organisation for Economic Co-operation and Development (OECD)

Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg